Agios Pharm (AGIO) — Cash Flow Quality Index
Latest as of September 2024:
-0.09x
Agios Pharm (AGIO) has a Cash Flow Quality Index of -0.09x as of September 2024. Operating cash flow of $-84.22 Million is below net income of $947.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AGIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.09x
Operating CF / Net Income
Operating Cash Flow
$-84.22 Million
USD
Net Income
$947.91 Million
USD
Data as of
Sep 2024
Most recent filing
Agios Pharm Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Agios Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Agios Pharm (AGIO) cash flow conversion.
Annual Cash Flow Quality Index for Agios Pharm (2024–2024)
Year-by-year earnings quality comparison for Agios Pharm.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.58x | $-389.84 Million | $673.73 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.